BCD-085

DRUG5 trials

Sponsors

Biocad

Conditions

Ankylosing SpondylitisLiver Cirrhosis, BiliaryPsoriasisPsoriatic Arthritis

Phase 2

Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis

CompletedNCT02763111

BiocadAnkylosing Spondylitis

Start: 2016-09-30End: 2017-06-30Updated: 2021-11-01

International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis

CompletedNCT02762994

BiocadPsoriasis

Start: 2016-06-30End: 2017-05-31Updated: 2021-03-23

Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis

TerminatedNCT03476993

BiocadLiver Cirrhosis, Biliary

Start: 2018-04-27End: 2019-07-01Updated: 2019-10-11

Phase 3

International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis

CompletedNCT03447704

BiocadAnkylosing Spondylitis

Start: 2018-02-09End: 2022-03-31Updated: 2025-07-08

Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritis

CompletedNCT03598751

BiocadPsoriatic Arthritis

Start: 2018-07-25End: 2022-08-31Updated: 2025-07-08

Related Papers

Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study.

2022-08-318 citations

Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo-Controlled PLANETA Clinical Trial.

2021-05-3123 citations

Antibodies to watch in 2020.

2020-01-01328 citations

Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext

Vestnik dermatologii i venerologii2019-10-0217 citations